Author： Streubel Alexander Siepmann Juergen Bodmeier Roland
Publisher： Informa Healthcare
ISSN： 1742-5247
Source： Expert Opinion on Drug Delivery, Vol.3, Iss.2, 2006-03, pp. : 217-233
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
A controlled drug delivery system with prolonged residence time in the stomach is of particular interest for drugs that i) are locally active in the stomach, ii) have an absorption window in the stomach or in the upper small intestine, iii) are unstable in the intestinal or colonic environment, or iv) exhibit low solubility at high pH values. This article gives an overview of the parameters affecting gastric emptying in humans as well as on the main concepts used to design pharmaceutical dosage forms with prolonged gastric residence times. In particular, bioadhesive, size-increasing and floating drug delivery systems are presented and their major advantages and shortcomings are discussed. Both single- and multiple-unit dosage forms are reviewed and, if available, results from in vivo trials are reported.
Related content
By Pawar Vivek K Kansal Shaswat Asthana Shalini Chourasia Manish K
Expert Opinion on Drug Delivery, Vol. 9, Iss. 5, 2012-05 ,pp. :
Access to resources
Recommend
Intracochlear drug delivery systems
Expert Opinion on Drug Delivery, Vol. 8, Iss. 9, 2011-09 ,pp. :
Paclitaxel drug delivery systems
By Zhang Zhiping Mei Lin Feng Si-Shen
Expert Opinion on Drug Delivery, Vol. 10, Iss. 3, 2013-03 ,pp. :